EPAS1 and neoplasm: In addition, the association of molecular dysregulation in DNA number, mRNA expression, and mutations in ESCC along the clinical significance of the gene has provided critical insights of tumor-promoting properties of EPAS1 in the pathogenesis of ESCC.